{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T12:58:34Z","timestamp":1793451514779,"version":"4.5.0"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T00:00:00Z","timestamp":1748217600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004710","name":"Umberto Veronesi Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003246","name":"NWO","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004385","name":"Universiteit Gent","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004385","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003441","name":"Universitair Ziekenhuis Gent","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003441","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.jconrel.2025.113890","type":"journal-article","created":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T01:58:30Z","timestamp":1748224710000},"page":"113890","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Injectable thermosensitive hydrogel for local and controlled delivery of siRNA-STAT3 polyplexes to treat advanced-stage ovarian cancer"],"prefix":"10.1016","volume":"384","author":[{"given":"Cristina","family":"Casadidio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel H.A.M.","family":"Fens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lies A.L.","family":"Fliervoet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Censi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina","family":"Vermonden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.jconrel.2025.113890_bb0005","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/nrc4019","article-title":"Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer","volume":"15","author":"Bowtell","year":"2015","journal-title":"Nat. Rev. Cancer"},{"issue":"10177","key":"10.1016\/j.jconrel.2025.113890_bb0010","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/S0140-6736(18)32552-2","article-title":"Epithelial ovarian cancer","volume":"393","author":"Lheureux","year":"2019","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.jconrel.2025.113890_bb0015","doi-asserted-by":"crossref","first-page":"833","DOI":"10.3390\/ijms23020833","article-title":"Ovarian cancer cells in ascites form aggregates that display a hybrid epithelial-mesenchymal phenotype and allows survival and proliferation of metastasizing cells","volume":"23","author":"Capellero","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"17","key":"10.1016\/j.jconrel.2025.113890_bb0020","doi-asserted-by":"crossref","first-page":"4318","DOI":"10.3390\/cancers13174318","article-title":"Malignant ascites in ovarian cancer: cellular, acellular, and biophysical determinants of molecular characteristics and therapy response","volume":"13","author":"Rickard","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.jconrel.2025.113890_bb0025","doi-asserted-by":"crossref","first-page":"256","DOI":"10.3389\/fonc.2013.00256","article-title":"Getting to know ovarian cancer ascites: opportunities for targeted therapy-based translational research","volume":"3","author":"Ahmed","year":"2013","journal-title":"Front. Oncol."},{"issue":"5","key":"10.1016\/j.jconrel.2025.113890_bb0030","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1093\/annonc\/mdl499","article-title":"Pattern and prognostic factors in patients with malignant ascites: a retrospective study","volume":"18","author":"Ayantunde","year":"2007","journal-title":"Ann. Oncol."},{"issue":"8","key":"10.1016\/j.jconrel.2025.113890_bb0035","doi-asserted-by":"crossref","first-page":"e417","DOI":"10.1016\/S1470-2045(19)30401-2","article-title":"Rational combinations of immunotherapy with radiotherapy in ovarian cancer","volume":"20","author":"Herrera","year":"2019","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.jconrel.2025.113890_bb0040","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.577869","article-title":"Immunotherapy for ovarian cancer: adjuvant, combination, and neoadjuvant","volume":"11","author":"Yang","year":"2020","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.jconrel.2025.113890_bb0045","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00280-017-3501-8","article-title":"Advances in ovarian cancer therapy","volume":"81","author":"Cortez","year":"2018","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"4","key":"10.1016\/j.jconrel.2025.113890_bb0050","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/nrc3432","article-title":"Meeting the challenge of ascites in ovarian cancer: new avenues for therapy and research","volume":"13","author":"Kipps","year":"2013","journal-title":"Nat. Rev. Cancer"},{"issue":"3","key":"10.1016\/j.jconrel.2025.113890_bb0055","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/nrg2006","article-title":"Strategies for silencing human disease using RNA interference","volume":"8","author":"Kim","year":"2007","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.jconrel.2025.113890_bb0060","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jconrel.2018.05.012","article-title":"siRNA in ovarian cancer\u2013delivery strategies and targets for therapy","volume":"283","author":"van den Brand","year":"2018","journal-title":"J. Control. Release"},{"issue":"38","key":"10.1016\/j.jconrel.2025.113890_bb0065","doi-asserted-by":"crossref","first-page":"32520","DOI":"10.1021\/acsami.7b09511","article-title":"Building stable MMP2-responsive multifunctional polymeric micelles by an all-in-one polymer\u2013lipid conjugate for tumor-targeted intracellular drug delivery","volume":"9","author":"Yao","year":"2017","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"36","key":"10.1016\/j.jconrel.2025.113890_bb0070","doi-asserted-by":"crossref","first-page":"5651","DOI":"10.1039\/C8TB01795F","article-title":"Polymers and hydrogels for local nucleic acid delivery","volume":"6","author":"Fliervoet","year":"2018","journal-title":"J. Mater. Chem. B"},{"issue":"18","key":"10.1016\/j.jconrel.2025.113890_bb0075","doi-asserted-by":"crossref","first-page":"10347","DOI":"10.1039\/D0NR03147J","article-title":"Local release of siRNA using polyplex-loaded thermosensitive hydrogels","volume":"12","author":"Fliervoet","year":"2020","journal-title":"Nanoscale"},{"key":"10.1016\/j.jconrel.2025.113890_bb0080","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.jconrel.2023.01.014","article-title":"Targeted GATA3 knockdown in activated T cells via pulmonary siRNA delivery as novel therapy for allergic asthma","volume":"354","author":"Kandil","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.113890_bb0085","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jconrel.2019.10.030","article-title":"Treatment of acute lung injury and early-and late-stage pulmonary fibrosis with combination emulsion siRNA polyplexes","volume":"314","author":"Wang","year":"2019","journal-title":"J. Control. Release"},{"issue":"11","key":"10.1016\/j.jconrel.2025.113890_bb0090","doi-asserted-by":"crossref","first-page":"5515","DOI":"10.1021\/acs.molpharmaceut.3c00397","article-title":"Effect of Polyplex size on penetration into tumor spheroids","volume":"20","author":"Casadidio","year":"2023","journal-title":"Mol. Pharm."},{"issue":"6","key":"10.1016\/j.jconrel.2025.113890_bb0095","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1200\/JCO.2005.05.2456","article-title":"Intraperitoneal chemotherapy of ovarian cancer: a review, with a focus on practical aspects of treatment","volume":"24","author":"Markman","year":"2006","journal-title":"J. Clin. Oncol."},{"issue":"12","key":"10.1016\/j.jconrel.2025.113890_bb0100","first-page":"3380","article-title":"Direct diffusion of cis-diamminedichloroplatinum (II) in intraperitoneal rat tumors after intraperitonal chemotherapy: a comparison with systemic chemotherapy","volume":"49","author":"Los","year":"1989","journal-title":"Cancer Res."},{"issue":"9","key":"10.1016\/j.jconrel.2025.113890_bb0105","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1080\/17425247.2021.1896493","article-title":"Pharmaceutical strategies in improving anti-tumour efficacy and safety of intraperitoneal therapy for peritoneal metastasis","volume":"18","author":"Wang","year":"2021","journal-title":"Expert Opin. Drug Deliv."},{"issue":"5","key":"10.1016\/j.jconrel.2025.113890_bb0110","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s11095-009-0031-z","article-title":"Drug delivery systems for intraperitoneal therapy","volume":"27","author":"Bajaj","year":"2010","journal-title":"Pharm. Res."},{"issue":"3","key":"10.1016\/j.jconrel.2025.113890_bb0115","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.jconrel.2012.08.010","article-title":"A micelle-shedding thermosensitive hydrogel as sustained release formulation","volume":"162","author":"de Graaf","year":"2012","journal-title":"J. Control. Release"},{"issue":"7","key":"10.1016\/j.jconrel.2025.113890_bb0120","doi-asserted-by":"crossref","first-page":"5757","DOI":"10.1021\/nn300842a","article-title":"Injectable polyplex hydrogel for localized and long-term delivery of siRNA","volume":"6","author":"Kim","year":"2012","journal-title":"ACS Nano"},{"issue":"6","key":"10.1016\/j.jconrel.2025.113890_bb0125","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202008364","article-title":"MMP-2 responsive unidirectional hydrogel-electrospun patch loading TGF-\u03b21 siRNA Polyplexes for Peritendinous anti-adhesion","volume":"31","author":"Cai","year":"2021","journal-title":"Adv. Funct. Mater."},{"issue":"18","key":"10.1016\/j.jconrel.2025.113890_bb0130","doi-asserted-by":"crossref","first-page":"4493","DOI":"10.1016\/j.biomaterials.2013.02.050","article-title":"An injectable cell penetrable nano-polyplex hydrogel for localized siRNA delivery","volume":"34","author":"Kim","year":"2013","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.jconrel.2025.113890_bb0135","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1021\/acs.biomac.6b01378","article-title":"Injectable, guest\u2013host assembled polyethylenimine hydrogel for siRNA delivery","volume":"18","author":"Wang","year":"2017","journal-title":"Biomacromolecules"},{"issue":"27","key":"10.1016\/j.jconrel.2025.113890_bb0140","doi-asserted-by":"crossref","first-page":"7970","DOI":"10.1016\/j.biomaterials.2014.05.070","article-title":"Targetable micelleplex hydrogel for long-term, effective, and systemic siRNA delivery","volume":"35","author":"Kim","year":"2014","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.jconrel.2025.113890_bb0145","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1021\/acs.biomac.9b00896","article-title":"Structure and dynamics of thermosensitive pDNA polyplexes studied by time-resolved fluorescence spectroscopy","volume":"21","author":"Fliervoet","year":"2019","journal-title":"Biomacromolecules"},{"issue":"21","key":"10.1016\/j.jconrel.2025.113890_bb0150","doi-asserted-by":"crossref","first-page":"9388","DOI":"10.1021\/la048354h","article-title":"Physicochemical characterization of degradable thermosensitive polymeric micelles","volume":"20","author":"Soga","year":"2004","journal-title":"Langmuir"},{"issue":"10","key":"10.1016\/j.jconrel.2025.113890_bb0155","doi-asserted-by":"crossref","first-page":"8870","DOI":"10.1021\/nn403325f","article-title":"Balancing cationic and hydrophobic content of PEGylated siRNA polyplexes enhances endosome escape, stability, blood circulation time, and bioactivity in vivo","volume":"7","author":"Nelson","year":"2013","journal-title":"ACS Nano"},{"issue":"4","key":"10.1016\/j.jconrel.2025.113890_bb0160","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1021\/bc980148w","article-title":"Structure\u2212 activity relationships of water-soluble cationic methacrylate\/methacrylamide polymers for nonviral gene delivery","volume":"10","author":"van de Wetering","year":"1999","journal-title":"Bioconjug. Chem."},{"issue":"7","key":"10.1016\/j.jconrel.2025.113890_bb0165","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1021\/ar200242z","article-title":"Application of living free radical polymerization for nucleic acid delivery","volume":"45","author":"Chu","year":"2012","journal-title":"Acc. Chem. Res."},{"issue":"16","key":"10.1016\/j.jconrel.2025.113890_bb0170","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1002\/marc.201000154","article-title":"Hydrazine as a nucleophile and antioxidant for fast aminolysis of RAFT polymers in air","volume":"31","author":"Shen","year":"2010","journal-title":"Macromol. Rapid Commun."},{"issue":"5","key":"10.1016\/j.jconrel.2025.113890_bb0175","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.progpolymsci.2012.09.008","article-title":"Progress of RAFT based polymers in gene delivery","volume":"38","author":"Ahmed","year":"2013","journal-title":"Prog. Polym. Sci."},{"issue":"19","key":"10.1016\/j.jconrel.2025.113890_bb0180","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1002\/marc.200600436","article-title":"Facile and efficient one-pot transformation of RAFT polymer end groups via a mild Aminolysis\/Michael addition sequence","volume":"27","author":"Qiu","year":"2006","journal-title":"Macromol. Rapid Commun."},{"issue":"4","key":"10.1016\/j.jconrel.2025.113890_bb0185","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1002\/marc.201300690","article-title":"Straightforward RAFT procedure for the synthesis of heterotelechelic poly (acrylamide) s","volume":"35","author":"Wallyn","year":"2014","journal-title":"Macromol. Rapid Commun."},{"issue":"2","key":"10.1016\/j.jconrel.2025.113890_bb0190","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1039\/B9PY00340A","article-title":"End group removal and modification of RAFT polymers","volume":"1","author":"Willcock","year":"2010","journal-title":"Polym. Chem."},{"issue":"13","key":"10.1016\/j.jconrel.2025.113890_bb0195","doi-asserted-by":"crossref","first-page":"5771","DOI":"10.1021\/ma100606a","article-title":"In situ forming hydrogels by tandem thermal gelling and Michael addition reaction between thermosensitive triblock copolymers and thiolated hyaluronan","volume":"43","author":"Censi","year":"2010","journal-title":"Macromolecules"},{"issue":"3","key":"10.1016\/j.jconrel.2025.113890_bb0200","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.ejpb.2014.07.005","article-title":"Polyethylene glycol (PEG)\u2013poly (N-isopropylacrylamide)(PNIPAAm) based thermosensitive injectable hydrogels for biomedical applications","volume":"88","author":"Alexander","year":"2014","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2025.113890_bb0205","first-page":"3","article-title":"Poly (N-isopropylacrylamide): physicochemical properties and biomedical applications","author":"Najafi","year":"2018","journal-title":"Temper.Respons. Polym. Chem. Proper. Appl."},{"issue":"12","key":"10.1016\/j.jconrel.2025.113890_bb0210","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.1158\/1535-7163.MCT-14-0077","article-title":"Targeting JAK1\/STAT3 signaling suppresses tumor progression and metastasis in a peritoneal model of human ovarian cancer","volume":"13","author":"Wen","year":"2014","journal-title":"Mol. Cancer Ther."},{"issue":"12","key":"10.1016\/j.jconrel.2025.113890_bb0215","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1038\/sj.bjc.6604803","article-title":"Efficacy assessment of sustained intraperitoneal paclitaxel therapy in a murine model of ovarian cancer using bioluminescent imaging","volume":"99","author":"Vassileva","year":"2008","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/j.jconrel.2025.113890_bb0220","doi-asserted-by":"crossref","first-page":"180","DOI":"10.3390\/s110100180","article-title":"In vivo bioluminescent imaging (BLI): noninvasive visualization and interrogation of biological processes in living animals","volume":"11","author":"Close","year":"2010","journal-title":"Sensors"},{"issue":"S1","key":"10.1016\/j.jconrel.2025.113890_bb0225","first-page":"S7","article-title":"Validity of bioluminescence measurements for noninvasive in vivo imaging of tumor load in small animals","volume":"43","author":"Klerk","year":"2007","journal-title":"Biotechniques"},{"issue":"5","key":"10.1016\/j.jconrel.2025.113890_bb0230","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1021\/bc000015m","article-title":"Anomalous fluorescence enhancement of Cy3 and Cy3. 5 versus anomalous fluorescence loss of Cy5 and Cy7 upon covalent linking to IgG and noncovalent binding to avidin","volume":"11","author":"Gruber","year":"2000","journal-title":"Bioconjug. Chem."},{"issue":"4","key":"10.1016\/j.jconrel.2025.113890_bb0235","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1002\/jmri.20852","article-title":"A dendrimer-based nanosized contrast agent dual-labeled for magnetic resonance and optical fluorescence imaging to localize the sentinel lymph node in mice","volume":"25","author":"Koyama","year":"2007","journal-title":"J. Magn. Reson. Imaging"},{"issue":"1","key":"10.1016\/j.jconrel.2025.113890_bb0240","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1158\/1535-7163.MCT-08-0862","article-title":"In vivo target-specific activatable near-infrared optical labeling of humanized monoclonal antibodies","volume":"8","author":"Ogawa","year":"2009","journal-title":"Mol. Cancer Ther."},{"issue":"1","key":"10.1016\/j.jconrel.2025.113890_bb0245","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.copbio.2007.01.003","article-title":"Fluorescence imaging in vivo: recent advances","volume":"18","author":"Rao","year":"2007","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.jconrel.2025.113890_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.121189","article-title":"The safe and effective intraperitoneal chemotherapy with cathepsin B-specific doxorubicin prodrug nanoparticles in ovarian cancer with peritoneal carcinomatosis","volume":"279","author":"Kim","year":"2021","journal-title":"Biomaterials"},{"issue":"4","key":"10.1016\/j.jconrel.2025.113890_bb0255","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1158\/1535-7163.MCT-15-0713-T","article-title":"Paclitaxel-loaded polymersomes for enhanced intraperitoneal chemotherapy","volume":"15","author":"Sim\u00f3n-Gracia","year":"2016","journal-title":"Mol. Cancer Ther."},{"issue":"9","key":"10.1016\/j.jconrel.2025.113890_bb0260","doi-asserted-by":"crossref","first-page":"5397","DOI":"10.1039\/D0CS01127D","article-title":"Understanding nanoparticle endocytosis to improve targeting strategies in nanomedicine","volume":"50","author":"de Almeida","year":"2021","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.jconrel.2025.113890_bb0265","doi-asserted-by":"crossref","first-page":"9447","DOI":"10.2147\/IJN.S274289","article-title":"Endocytosis and organelle targeting of nanomedicines in cancer therapy","author":"Wang","year":"2020","journal-title":"Int. J. Nanomedicine"},{"issue":"9","key":"10.1016\/j.jconrel.2025.113890_bb0270","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1016\/j.biomaterials.2012.11.058","article-title":"In vivo disassembly of IV administered siRNA matrix nanoparticles at the renal filtration barrier","volume":"34","author":"Naeye","year":"2013","journal-title":"Biomaterials"},{"issue":"4","key":"10.1016\/j.jconrel.2025.113890_bb0275","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1002\/bit.21285","article-title":"Effect of siRNA nuclease stability on the in vitro and in vivo kinetics of siRNA-mediated gene silencing","volume":"97","author":"Bartlett","year":"2007","journal-title":"Biotechnol. Bioeng."},{"issue":"2","key":"10.1016\/j.jconrel.2025.113890_bb0280","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/nrd2742","article-title":"Knocking down barriers: advances in siRNA delivery","volume":"8","author":"Whitehead","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.jconrel.2025.113890_bb0285","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ddtec.2005.05.006","article-title":"Subcutaneous drug delivery and the role of the lymphatics","volume":"2","author":"McLennan","year":"2005","journal-title":"Drug Discov. Today Technol."},{"issue":"4","key":"10.1016\/j.jconrel.2025.113890_bb0290","first-page":"1381","article-title":"Hyaluronic acid conjugated nanoparticle delivery of siRNA against TWIST reduces tumor burden and enhances sensitivity to cisplatin in ovarian cancer, nanomedicine: nanotechnology","volume":"14","author":"Shahin","year":"2018","journal-title":"Biol. Med."},{"issue":"1","key":"10.1016\/j.jconrel.2025.113890_bb0295","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ymthe.2017.11.006","article-title":"Blocking stemness and metastatic properties of ovarian cancer cells by targeting p70S6K with dendrimer nanovector-based siRNA delivery","volume":"26","author":"Ma","year":"2018","journal-title":"Mol. Ther."},{"issue":"4","key":"10.1016\/j.jconrel.2025.113890_bb0300","doi-asserted-by":"crossref","DOI":"10.1593\/neo.101372","article-title":"Targeted delivery of small interfering RNA using reconstituted high-density lipoprotein nanoparticles","volume":"13","author":"Shahzad","year":"2011","journal-title":"Neoplasia"},{"issue":"8","key":"10.1016\/j.jconrel.2025.113890_bb0305","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1158\/0008-5472.CAN-13-2433","article-title":"HO-3867, a safe STAT3 inhibitor, is selectively cytotoxic to ovarian cancer","volume":"74","author":"Rath","year":"2014","journal-title":"Cancer Res."},{"issue":"8","key":"10.1016\/j.jconrel.2025.113890_bb0310","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1158\/0008-5472.CAN-16-1115","article-title":"The STAT3-miRNA-92-Wnt signaling pathway regulates spheroid formation and malignant progression in ovarian cancer","volume":"77","author":"Chen","year":"2017","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2025.113890_bb0315","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.colsurfb.2015.01.034","article-title":"Knockdown of STAT3 expression in SKOV3 cells by biodegradable siRNA\u2013PLGA\/CSO conjugate micelles","volume":"127","author":"Zhao","year":"2015","journal-title":"Colloids Surf. B: Biointerfaces"},{"issue":"38","key":"10.1016\/j.jconrel.2025.113890_bb0320","doi-asserted-by":"crossref","first-page":"34634","DOI":"10.1021\/acsami.9b10182","article-title":"Injectable and quadruple-functional hydrogel as an alternative to intravenous delivery for enhanced tumor targeting","volume":"11","author":"Zhang","year":"2019","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"4","key":"10.1016\/j.jconrel.2025.113890_bb0325","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1158\/1078-0432.CCR-22-0997","article-title":"Selectively targeting STAT3 using a small molecule inhibitor is a potential therapeutic strategy for pancreatic cancer","volume":"29","author":"Chen","year":"2023","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2025.113890_bb0330","doi-asserted-by":"crossref","unstructured":"H. Chen, A. Bian, L.-f. Yang, X. Yin, J. Wang, C. Ti, Y. Miao, S. Peng, S. Xu, M. Liu, Targeting STAT3 by a small molecule suppresses pancreatic cancer progression, Oncogene 40(8) (2021) 1440\u20131457.","DOI":"10.1038\/s41388-020-01626-z"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925005103?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925005103?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T05:00:50Z","timestamp":1779512450000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365925005103"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":66,"alternative-id":["S0168365925005103"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.113890","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Injectable thermosensitive hydrogel for local and controlled delivery of siRNA-STAT3 polyplexes to treat advanced-stage ovarian cancer","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.113890","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"113890"}}